← Back
$UTHR All transactions

UNITED THERAPEUTICS Corp

▼ SELL 10b5-1 Plan

$ Value

$1.3M

Shares

2,625

Price

$485

Filed

Mar 9

Insider

Name

ROTHBLATT MARTINE A

Title

Chairperson & CEO

CIK

0001106578

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-05

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

2,714

Footnotes

This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. | This transaction was executed in multiple trades at prices ranging from $479.14 to $480.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $480.28 to $481.24. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $481.52 to $482.48. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $482.52 to $483.41. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $483.53 to $484.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $484.61 to $485.58. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $485.61 to $486.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $486.62 to $487.60. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $487.67 to $488.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke.

Filing Info

Accession No.

0001106578-26-000005

Form Type

4

Issuer CIK

0001082554

ROTHBLATT MARTINE A's History

Date Ticker Type Value
2026-04-22 UTHR M $1.4M
2026-04-22 UTHR $299K
2026-04-22 UTHR $944K
2026-04-22 UTHR $423K
2026-04-22 UTHR $812K
2026-04-22 UTHR $985K
2026-04-22 UTHR $1.0M
2026-04-22 UTHR $636K
2026-04-22 UTHR $348K
2026-04-22 UTHR M $0

Other Insiders at UTHR (90d)

Insider Bought Sold Last
ROTHBLATT MARTINE A
Chairperson & CEO
$192.5M 2026-04-22
KURZWEIL RAY $2.4M 2026-03-04
PATUSKY CHRISTOPHER $579K 2026-04-17
MAHON PAUL A
EVP & GENERAL COUNSEL
$25.9M 2026-04-16
CAUSEY CHRISTOPHER $1.3M 2026-03-30
Thompson Tommy G $2.1M 2026-03-26
Olian Judy D. $417K 2026-03-23
EDGEMOND JAMES
CFO AND TREASURER
$50.8M 2026-04-20
BENKOWITZ MICHAEL
PRESIDENT AND COO
$60.0M 2026-03-15
MALCOLM JAN $97K 2026-03-17